ProColl Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $401K

  • Investors
  • 5

ProColl General Information

Description

Operator of a synthetic biology company intended to manufacture recombinant collagen and other high-value proteins at scale. The company specializes in empowering research into collagen-based biotechnologies through an innovative range of products, provides purity collagen products, and undergoes a rapid portfolio development of new-to-market products and medical devices with novel applications, enabling research-grade collagens, with market-leading specifications, at a cost-effective price for researchers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Bevan Buckland Llp Ground Floor Cardigan House
  • Castle Court Swansea Enterprise Park
  • Swansea SA7 9LA
  • Wales, United Kingdom
Primary Industry
Biotechnology
Corporate Office
  • C/O Bevan Buckland Llp Ground Floor Cardigan House
  • Castle Court Swansea Enterprise Park
  • Swansea SA7 9LA
  • Wales, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProColl Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 21-Dec-2020 $401K Completed Generating Revenue
3. Grant 15-Jul-2019 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 29-Sep-2018 Completed Startup
To view ProColl’s complete valuation and funding history, request access »

ProColl Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view ProColl’s complete cap table history, request access »

ProColl Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a synthetic biology company intended to manufacture recombinant collagen and other high-value proteins at sc
Biotechnology
Swansea, United Kingdom
2 As of 2025

Rehovot, Israel
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProColl Competitors (5)

One of ProColl’s 5 competitors is CollPlant Biotechnologies, a Corporation company based in Rehovot, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CollPlant Biotechnologies Corporation Rehovot, Israel
Geltor Venture Capital-Backed Emeryville, CA
Ginkgo Bioworks Formerly VC-backed Boston, MA
Advanced BioMatrix Formerly VC-backed Carlsbad, CA
Rosen's Diversified Private Debt Financed Fairmont, MN
You’re viewing 5 of 5 competitors. Get the full list »

ProColl Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProColl Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Meltwind Advisory Venture Capital Minority
Swansea Innovations Venture Capital Minority
Royal Academy of Engineering Not-For-Profit Venture Capital
Swansea University University Minority
ICURe Accelerator/Incubator
To view ProColl’s complete investors history, request access »

ProColl FAQs

  • When was ProColl founded?

    ProColl was founded in 2018.

  • Where is ProColl headquartered?

    ProColl is headquartered in Swansea, United Kingdom.

  • What is the size of ProColl?

    ProColl has 2 total employees.

  • What industry is ProColl in?

    ProColl’s primary industry is Biotechnology.

  • Is ProColl a private or public company?

    ProColl is a Private company.

  • What is the current valuation of ProColl?

    The current valuation of ProColl is .

  • What is ProColl’s current revenue?

    The current revenue for ProColl is .

  • How much funding has ProColl raised over time?

    ProColl has raised $401K.

  • Who are ProColl’s investors?

    Meltwind Advisory, Swansea Innovations, Royal Academy of Engineering, Swansea University, and ICURe have invested in ProColl.

  • Who are ProColl’s competitors?

    CollPlant Biotechnologies, Geltor, Ginkgo Bioworks, Advanced BioMatrix, and Rosen's Diversified are competitors of ProColl.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process